Vitamin D-3 regulation of stromelysin-1 (MMP-3) in chondrocyte cultures is mediated by protein kinase C

被引:0
|
作者
Schmitz, JP
Schwartz, Z
Sylvia, VL
Dean, DD
Calderon, F
Boyan, BD
机构
[1] UNIV TEXAS, HLTH SCI CTR, DEPT ORTHOPAED, SAN ANTONIO, TX 78284 USA
[2] UNIV TEXAS, HLTH SCI CTR, DEPT ORAL & MAXILLOFACIAL SURG, SAN ANTONIO, TX 78284 USA
[3] UNIV TEXAS, HLTH SCI CTR, DEPT BIOCHEM, SAN ANTONIO, TX 78284 USA
[4] UNIV TEXAS, HLTH SCI CTR, DEPT PERIODONT, SAN ANTONIO, TX 78284 USA
[5] HEBREW UNIV JERUSALEM, HADASSAH FAC DENT MED, IL-91010 JERUSALEM, ISRAEL
关键词
D O I
10.1002/(SICI)1097-4652(199609)168:3<570::AID-JCP9>3.3.CO;2-S
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Matrix metalloproteinases (MMPs) are a group of enzymes with the potential to degrade extracellular matrix proteins. One of the MMPs, stromelysin-1 (MMP-3) has been localized to extracellular matrix vesicles in growth plate chondrocyte cultures, suggesting involvement of this enzyme in remodeling of the extracellular matrix during endochondral development, a process which is regulated by the vitamin D metabolites, 1,25-(OH)(2)D-3 and 24,25-(OH)(2)D-3. To determine whether stromelysin-1 is regulated by vitamin D as well, confluent cultures of cells derived from growth zone (GC) and resting zone (RC) rat costochondral cartilage were treated with 1 alpha,25-(OH)(2)D-3 (1,25) and 24R,25-(OH)(2)D-3 (24,25), respectively, and the effect on stromelysin-1 assessed by casein gel zymography and Western blots. Although stromelysin-1 activity was enriched in the matrix vesicle fraction, only the plasma membrane enzyme was affected by the treatment; 1,25 and 24,25 caused a marked decrease in plasma membrane stromelysin-1 activity in their target cells. Since plasma-membrane protein kinase C (PKC) activity is stimulated by 1,25 and 24,25, we hypothesized that stromelysin-1 activity was regulated by the vitamin D metabolites via PKC-dependent phosphorylation. To test this, membrane fractions (containing endogenous PKC alpha and zeta as well as stromelysin-1) were incubated in the presence of purified rat brain PKC and/or recombinant human (rh) stromelysin-1 and [gamma(32)P]-ATP and anti-stromelysin-1 immunoprecipitates were analyzed by autoradiography and Western blots. Immuno-phospho-stromelysin-1 was localized to a 52-kDa band in the plasma membrane fraction only; no phosphorylation was observed in the matrix vesicle fraction. Selective inhibitors of PKC activity demonstrated that phosphorylation was inhibited by H7 and low concentrations of H8, but not by HA1004, indicating that PKC, not PKA, was responsible. Protein phosphatase 2A(1) (PP2A), a serine/threonine-specific phosphatase, selectively removed the radiolabel in a time-dependent manner, providing further support for a PKC-dependent phosphorylation mechanism. Incubation of resting zone cell plasma membranes with 24,25, but not 1,25, resulted in phosphorylation of stromelysin-1, demonstrating that the nongenomic effect was metabolite-specific. This suggests that this may be one mechanism by which vitamin D metabolites regulate stromelysin-1 activity and that PKC-dependent phosphorylation inhibits the metalloproteinase. (C) 1996 Wiley-Liss, Inc.
引用
收藏
页码:570 / 579
页数:10
相关论文
共 50 条
  • [1] Orally active inhibitors of stromelysin-1 (MMP-3)
    Chapman, KT
    Durette, PL
    Caldwell, CG
    Sperow, KM
    Niedzwiecki, LM
    Harrison, RK
    Saphos, C
    Christen, AJ
    Olszewski, JM
    Moore, VL
    MacCoss, M
    Hagmann, WK
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (07) : 803 - 806
  • [2] Differential regulation of MMP-13 (collagenase-3) and MMP-3 (stromelysin-1) in mouse calvariae
    Peeters-Joris, C
    Hammani, K
    Singer, CF
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1998, 1405 (1-3): : 14 - 28
  • [3] INHIBITION OF STROMELYSIN-1 (MMP-3) BY PEPTIDYL PHOSPHINIC ACIDS
    GOULET, JL
    KINNEARY, JF
    DURETTE, PL
    STEIN, RL
    HARRISON, RK
    IZQUIERDOMARTIN, M
    KUO, DW
    LIN, TY
    HAGMANN, WK
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (10) : 1221 - 1224
  • [4] Discovery of potent and selective inhibitors of stromelysin-1 (MMP-3).
    Fray, MJ
    Burslem, MF
    Dack, KN
    Dickinson, RP
    Huggins, JP
    Occleston, NL
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2002, 224 : U80 - U80
  • [5] Chiral synthesis of C-carboxyalkyl dipeptide inhibitors of stromelysin-1 (MMP-3)
    Ponpipom, MM
    Hagmann, WK
    TETRAHEDRON, 1999, 55 (22) : 6749 - 6758
  • [6] MMP-3/stromelysin-1 promotes early and late tumorigenesis.
    Sternlicht, MD
    Lukashev, M
    Lochter, A
    Bissell, MJ
    Werb, Z
    MOLECULAR BIOLOGY OF THE CELL, 1998, 9 : 6A - 6A
  • [7] Stromelysin-1 (MMP-3)-independent gelatinase expression and activation in mice
    Lijnen, HR
    Silence, J
    Van Hoef, B
    Collen, D
    BLOOD, 1998, 91 (06) : 2045 - 2053
  • [8] Modulation of cell-associated plasminogen activation by stromelysin-1 (MMP-3)
    Ugwu, F
    Lemmens, G
    Collen, D
    Lijnen, HR
    THROMBOSIS AND HAEMOSTASIS, 1999, 82 (03) : 1127 - 1131
  • [9] Inhibition of stromelysin-1 (MMP-3) by P-1'-biphenylylethyl carboxyalkyl dipeptides
    Esser, CK
    Bugianesi, RL
    Caldwell, CG
    Chapman, KT
    Durette, PL
    Girotra, NN
    Kopka, IE
    Lanza, TJ
    Levorse, DA
    MacCoss, M
    Owens, KA
    Ponpipom, MM
    Simeone, JP
    Harrison, RK
    Niedzwiecki, L
    Becker, JW
    Marcy, AI
    Axel, MG
    Christen, AJ
    McDonnell, J
    Moore, VL
    Olszewski, JM
    Saphos, C
    Visco, DM
    Shen, F
    Colletti, A
    Krieter, PA
    Hagmann, WK
    JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (06) : 1026 - 1040
  • [10] Stromelysin-1 (MMP-3) regulation by big ET-1 (1-38) in human OA chondrocytes
    Roy-Beaudry, M
    Martel-Pelletier, J
    Filep, J
    Pelletier, JP
    Shipkolye, F
    Moldovan, F
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 115 - 115